FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075080570> ?p ?o ?g. }

• W2075080570 abstract "In line with international trends, methylphenidate prescriptions in Germany have been growing 20-fold over the last decade. This development has contributed to concern about potentially inappropriate and excessive psychostimulant treatment for youths. Objective: To clarify methylphenidate prescriptions for children and adolescents with ADHD, using the comprehensive medical claims database of Nordbaden/Germany, covering an insured population of 2.234m (hereof, 468,000 children and adolescents) in 2003. Methods: 11,245 children and adolescents with a diagnosis of ADHD (ICD-10-codes for “Hyperkinetic Disorder”, F90.0, F90.1) were identified. For a retrospective analysis of methylphenidate prescriptions by age, gender, and comorbid conduct disorder, administrative data from the organization of licensed physicians (Kassenaerztliche Vereinigung) in Nordbaden/Germany were combined with data from the regional vdak, an association of statutory sick funds. Results: For the regional population, methylphenidate treatment prevalence rates were approximately 1.7% (children) and 0.6% (adolescents). Among those with a diagnosis of ADHD, 4.3% of preschoolers (age 0-6) were administered methylphenidate. Among children (age 7-12), 35.1% (95%-CI, 33.0%-37.1%) were prescribed methylphenidate; in adolescents (age 13-19), this rate increased to 46.2% (42.7%-49.8%). Across ADHD groups analyzed, children with concomitant conduct disorder (42.4%; 39.4%-45.5% versus 27.9%; 26.2%-29.7%) and boys (34.4%; 32.6%-36.2% versus girls, 25.5%; 22.7%28.4%) were more likely to be treated with methylphenidate. Very few patients (<1%) received higher doses than recommended. Child and adolescent psychiatrists accounted for 35% of methylphenidate prescriptions for patients with ADHD (pediatricians, 40%; general practitioners, 12%). During 2003, the number of defined daily doses prescribed in Nordbaden increased by a compound annual growth rate of 27%. Conclusions: Though methylphenidate prescriptions continued to increase during 2003, the present data do not provide evidence for overuse. Of note, however, a limitation of administrative database analyses is lack of information on the accuracy of diagnoses. The low rate of methylphenidate prescriptions for preschoolers corresponds to clinical guidelines." @default.
• W2075080570 created "2016-06-24" @default.
• W2075080570 creator A5007001298 @default.
• W2075080570 creator A5023475997 @default.
• W2075080570 creator A5052645519 @default.
• W2075080570 creator A5071384594 @default.
• W2075080570 date "2006-11-01" @default.
• W2075080570 modified "2023-10-18" @default.
• W2075080570 title "IH4 METHYLPHENIDATE PRESCRIPTIONS FOR CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): NEW DATA FROM NORDBADEN/GERMANY" @default.
• W2075080570 doi "https://doi.org/10.1016/s1098-3015(10)63170-1" @default.
• W2075080570 hasPublicationYear "2006" @default.
• W2075080570 type Work @default.
• W2075080570 sameAs 2075080570 @default.
• W2075080570 citedByCount "1" @default.
• W2075080570 crossrefType "journal-article" @default.
• W2075080570 hasAuthorship W2075080570A5007001298 @default.
• W2075080570 hasAuthorship W2075080570A5023475997 @default.
• W2075080570 hasAuthorship W2075080570A5052645519 @default.
• W2075080570 hasAuthorship W2075080570A5071384594 @default.
• W2075080570 hasBestOaLocation W20750805701 @default.
• W2075080570 hasConcept C118552586 @default.
• W2075080570 hasConcept C187212893 @default.
• W2075080570 hasConcept C2426938 @default.
• W2075080570 hasConcept C2777112843 @default.
• W2075080570 hasConcept C2780783007 @default.
• W2075080570 hasConcept C2908647359 @default.
• W2075080570 hasConcept C2994409691 @default.
• W2075080570 hasConcept C3017694942 @default.
• W2075080570 hasConcept C71924100 @default.
• W2075080570 hasConcept C98274493 @default.
• W2075080570 hasConcept C99454951 @default.
• W2075080570 hasConceptScore W2075080570C118552586 @default.
• W2075080570 hasConceptScore W2075080570C187212893 @default.
• W2075080570 hasConceptScore W2075080570C2426938 @default.
• W2075080570 hasConceptScore W2075080570C2777112843 @default.
• W2075080570 hasConceptScore W2075080570C2780783007 @default.
• W2075080570 hasConceptScore W2075080570C2908647359 @default.
• W2075080570 hasConceptScore W2075080570C2994409691 @default.
• W2075080570 hasConceptScore W2075080570C3017694942 @default.
• W2075080570 hasConceptScore W2075080570C71924100 @default.
• W2075080570 hasConceptScore W2075080570C98274493 @default.
• W2075080570 hasConceptScore W2075080570C99454951 @default.
• W2075080570 hasLocation W20750805701 @default.
• W2075080570 hasOpenAccess W2075080570 @default.
• W2075080570 hasPrimaryLocation W20750805701 @default.
• W2075080570 hasRelatedWork W1967673591 @default.
• W2075080570 hasRelatedWork W2075080570 @default.
• W2075080570 hasRelatedWork W2104897638 @default.
• W2075080570 hasRelatedWork W2296792081 @default.
• W2075080570 hasRelatedWork W2316408060 @default.
• W2075080570 hasRelatedWork W2768405764 @default.
• W2075080570 hasRelatedWork W37634294 @default.
• W2075080570 hasRelatedWork W4244203158 @default.
• W2075080570 hasRelatedWork W4249974381 @default.
• W2075080570 hasRelatedWork W73601463 @default.
• W2075080570 isParatext "false" @default.
• W2075080570 isRetracted "false" @default.
• W2075080570 magId "2075080570" @default.
• W2075080570 workType "article" @default.